Signaling Pathways - Immunosuppressive Therapy - Bladder Carcinoma - Non-small Cell Lung Carcinoma - Myelofibrosis
清除全部
-
B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂 -
A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb（P糖蛋白）抑制剂 -
A8477 MK-8776 (SCH-900776)Target: ChkSummary: Chk1高效选择性抑制剂 -
A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂 -
A3573 LY2801653Target: METSummary: MET抑制剂 -
A3191 Ascomycin(FK 520)中文名: 长川霉素Target: phosphatasesSummary: FK-520 类似物，大环内酯类免疫抑制剂 -
A4365 Lovastatin中文名: 洛伐他汀Target: HMG-CoA ReductasesSummary: HMG-CoA还原酶抑制剂 -
A1915 Zebularine1 Citation中文名: 泽布拉林Target: DNA Methyltransferases|Cytidine deaminasesSummary: DNA甲基化抑制剂 -
A4212 Pomalidomide (CC-4047)中文名: 泊马度胺Summary: 抗肿瘤/抗血管生成的免疫调制剂 -
A4136 TG101348 (SAR302503)2 Citation中文名: 费德拉替尼Target: FLT3|JAK|c-RETSummary: JAK-2抑制剂